Lipoprotein (a) Evolution: Possible Benefits and Harm. Genetic and Non-Genetic Factors Influencing its Plasma Levels

Author(s): Peggy M. Kostakou, George Hatzigeorgiou, Vana Kolovou, Sophie Mavrogeni, Genovefa D. Kolovou*

Journal Name: Current Medicinal Chemistry

Volume 24 , Issue 10 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


The limited distribution of lipoprotein (a) (Lp(a)) to humans, Old World primates and to the European hedgehog, has raised considerable interest and speculation regarding its possible physiological role. Lp(a) has variable circulating concentrations (<0.1 – >100 mg/ml) which are highly genetically determined in humans. These characteristics gave rise to several theories concerning the origins and evolution of Lp(a). Lp(a) has a protective role after injury since Lp(a) particles bind to macrophages and platelets membrane receptors, leading to fibrin activation and injury healing. On the other hand, Lp(a) seems to be implicated in the formation of atheromatic plaques but also in cerebrovascular events and stenosis of the aortic valve.

The main genetic factor determining plasma Lp(a) levels is the Lp(a) gene (LPA). Most Caucasian people have normal plasma Lp(a) concentrations, but there is important distribution variation according to race. Women seem to have increased Lp(a) levels compared with men, while diabetes mellitus type 2 favours lower plasma Lp(a) levels. Nutrition, hormones and several drugs may also influence circulating Lp(a) levels.

Keywords: Lipoprotein (a), evolution, genetic factor, race, gender, hormones, drugs.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 20 January, 2017
Page: [969 - 978]
Pages: 10
DOI: 10.2174/0929867324666170120155412
Price: $65

Article Metrics

PDF: 46
HTML: 12
PRC: 1